Uchiyama H, Obata T, Tsubaki T, Sakaguchi N, Iikura Y, Aoki T
Department of Allergy, National Children's Hospital.
Arerugi. 1995 Feb;44(2):70-6.
In our Department, continuous isoproterenol inhalation therapy has been conducted on status asthmatics over the last 10 years. In the present study, we investigated whether there are any differences in the therapeutic efficacy of continuous inhalation of isoproterenol in the presence or absence of respiratory infections which may induce or aggravate asthma attacks. The treatment period was significantly longer in patients with pneumonia. Further prolongation of the treatment period was noted in patients with atelectasis. However, there were no apparent differences in therapeutic efficacy according to age or the severity of attacks. These findings suggest that continuous inhalation of isoproterenol is very effective for status asthmatics if respiratory infections are thoroughly controlled.
在过去10年里，我们科室对哮喘持续状态患者进行了持续异丙肾上腺素吸入治疗。在本研究中，我们调查了在存在或不存在可能诱发或加重哮喘发作的呼吸道感染情况下，持续吸入异丙肾上腺素的治疗效果是否存在差异。肺炎患者的治疗期明显更长。肺不张患者的治疗期有进一步延长。然而，根据年龄或发作严重程度，治疗效果并无明显差异。这些发现表明，如果呼吸道感染得到彻底控制，持续吸入异丙肾上腺素对哮喘持续状态患者非常有效。
